Key points from this week’s report:
Please refer to the attached PDF for the full report.
- The MSCI Asia Ex Japan index (AAXJ) breached its 50-DMA and is currently testing support along the confluence of its 100- and 200-DMAs. We recommend a cautious approach given the uncertainly around tariffs. Stay patient and wait for markets in a Downtrend to establish a new low and stage a follow-through day, before increasing risk.
- Singapore is in a Confirmed Uptrend. Hong Kong and China are in an Uptrend Under Pressure. Six markets, including India and Australia, are in a Rally Attempt. Four markets, including Japan, Taiwan and South Korea, are in a Downtrend.
- The U.S. is set to announce reciprocal tariffs, potentially 20% on most goods, creating business uncertainty, inflation risks and possible retaliation. India and South Korea are likely to be most affected due to high tariff rates and strong trade ties with the U.S.
- Despite market pressure, Hong Kong has held up well, with Health Care emerging as the strongest sector based on RS Rating, while Technology has weakened but remains a leader. Biotech and pharmaceutical stocks are outperforming. Refer to page 10 for a list of stocks of interest in Hong Kong.
- Highlighted Focus List Idea: Hansoh Pharmaceutical (HANP.HK; 3692 HK). Refer to page 8 for an annotated chart